588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cytokine-Induced Memory-Like Nk Cells Acute Myeloid Leukemia	Washington University School of Medicine	P2	CCC (51)
Docetaxel Acute Myeloid Leukemia	Syndax Pharmaceuticals	P2	CCC (51)
Everolimus Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P1/2	CCC (51)
Monalizumab Acute Myeloid Leukemia	Istituto Clinico Humanitas	P2	CCC (51)
Pomalidomide Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CCC (51)
Tocilizumab Acute Myeloid Leukemia	Nantes University Hospital	P2	CCC (51)
ze46-0134 Acute Myeloid Leukemia	Lomond Therapeutics Holdings, Inc.	P1/2	CCC (51)
18f-flt Acute Myeloid Leukemia	University of Oklahoma	P2	CCC (50)
Allogeneic Cd8+ Leukemia-Associated Antigens Specific T Cells Nexi-001 Acute Myeloid Leukemia	City of Hope Medical Center	P1/2	CCC (50)
Atezolizumab Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1/2	CCC (50)
Avastinib Acute Myeloid Leukemia	Ruijin Hospital	P2/3	CCC (50)
Bemcentinib Acute Myeloid Leukemia	BerGenBio ASA	P2	CCC (50)
Cobimetinib Acute Myeloid Leukemia	City of Hope Medical Center	P1	CCC (50)
Humanized, Dual-Affinity Re-Targeting, Or (Dart), Molecule That Recognizes Both Cd123 And Cd3 Acute Myeloid Leukemia	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (50)
Vedolizumab Acute Myeloid Leukemia	City of Hope Medical Center	P3	CCC (50)
Vibecotamab Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (50)
Anti-Cd33 Car T-Cells Acute Myeloid Leukemia	Zhejiang University	P1/2	CCC (49)
Avapritinib Acute Myeloid Leukemia	Ruijin Hospital	P2	CCC (49)
Ca-Edta Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (49)
cd45ra-depleted dli Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CCC (49)
cll1 car t-cells Acute Myeloid Leukemia	Tongji Hospital	P1/2	CCC (49)
DMSA Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (49)
Ficlatuzumab Acute Myeloid Leukemia	AVEO Pharmaceuticals, Inc.	P2	CCC (49)
Pacritinib Acute Myeloid Leukemia	University of Washington	P2	CCC (49)
Ptcy Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P2	CCC (49)
Pyronaridine Tetraphosphate Acute Myeloid Leukemia	Armaceutica, Inc.	P2	CCC (49)
8-chloroadenosine Acute Myeloid Leukemia	City of Hope Medical Center	P1/2	CCC (48)
Adaptnk Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P1/2	CCC (48)
Allogenic Nk Cells Acute Myeloid Leukemia	Xuzhou Medical University	P1/2	CCC (48)
Apamistamab-B10-Astatine At-211 Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1/2	CCC (48)
Apg 115 Acute Myeloid Leukemia	Ascentage Pharma Group Inc.	P1/2	CCC (48)
azd3632 Acute Myeloid Leukemia	AstraZeneca	P1/2	CCC (48)
Azd 5153 Acute Myeloid Leukemia	Beat AML, LLC	P1/2	CCC (48)
Bomedemstat Acute Myeloid Leukemia	Terrence J Bradley, MD	P1/2	CCC (48)
Bsb-1001 Acute Myeloid Leukemia	BlueSphere Bio, Inc	P1/2	CCC (48)
Calaspargase Pegol Acute Myeloid Leukemia	Children's Oncology Group	P2	CCC (48)
Cart84 Acute Myeloid Leukemia	Gyala Therapeutics	P1/2	CCC (48)
Dexrazoxane Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CCC (48)
Dna, D(3'-Amino-3'-Deoxy-P-Thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-Hydroxy-3-((1-Oxohexadecyl)Amino)Propyl) Hydrogen Phosphorothioate) Acute Myeloid Leukemia	Douglas Tremblay	P2	CCC (48)
Eltanexor Acute Myeloid Leukemia	Vanderbilt-Ingram Cancer Center	P1/2	CCC (48)
Fludeoxyglucose Acute Myeloid Leukemia	Children's Oncology Group	P3	CCC (48)
Hmpl-306 Acute Myeloid Leukemia	Hutchmed	P3	CCC (48)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CCC (48)
Letermovir Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (48)
Ligufalimab Acute Myeloid Leukemia	Akeso	P1/2	CCC (48)
Max-40279-01 Acute Myeloid Leukemia	Maxinovel Pty., Ltd.	P1/2	CCC (48)
Metformin Acute Myeloid Leukemia	Wake Forest University Health Sciences	P2	CCC (48)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (48)
NK-92 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (48)
Ocifisertib Acute Myeloid Leukemia	Treadwell Therapeutics, Inc	P1/2	CCC (48)

Showing 151 to 200 of 588 assets

PreviousPage 4 of 12Next